NASDAQ:HQY - Healthequity Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $86.92 -0.60 (-0.69 %) (As of 10/21/2018 01:05 PM ET)Previous Close$86.92Today's Range$86.1901 - $88.9452-Week Range$42.92 - $99.99Volume534,759 shsAverage Volume613,781 shsMarket Capitalization$5.39 billionP/E Ratio160.96Dividend YieldN/ABeta1.47 Company ProfileDiscussionAnalyst RatingsChartEarnings HistoryFinancialsInsider TradesHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email HealthEquity, Inc. provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only investment advisory services through Advisor, a Web-based tool. In addition, the company offers health reimbursement and flexible spending arrangements solutions; and Employee Retirement Income Security Act's plan administration and investment services. HealthEquity, Inc. was founded in 2002 and is headquartered in Draper, Utah. Receive HQY News and Ratings via Email Sign-up to receive the latest news and ratings for HQY and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Business services, not elsewhere classified Sub-IndustryN/A SectorMedical SymbolNASDAQ:HQY CUSIPN/A Webwww.healthequity.com Phone801-727-1000 Debt Debt-to-Equity RatioN/A Current Ratio19.91 Quick Ratio19.90 Price-To-Earnings Trailing P/E Ratio160.96 Forward P/E Ratio99.91 P/E Growth3.02 Sales & Book Value Annual Sales$229.52 million Price / Sales23.50 Cash Flow$0.8141 per share Price / Cash106.77 Book Value$5.71 per share Price / Book15.22 Profitability EPS (Most Recent Fiscal Year)$0.54 Net Income$47.36 million Net Margins23.81% Return on Equity12.58% Return on Assets11.89% Miscellaneous Employees1,027 Outstanding Shares62,050,000Market Cap$5.39 billion Healthequity (NASDAQ:HQY) Frequently Asked Questions What is Healthequity's stock symbol? Healthequity trades on the NASDAQ under the ticker symbol "HQY." How were Healthequity's earnings last quarter? Healthequity Inc (NASDAQ:HQY) posted its earnings results on Tuesday, September, 4th. The company reported $0.34 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.22 by $0.12. The business earned $71.10 million during the quarter, compared to analysts' expectations of $69.84 million. Healthequity had a return on equity of 12.58% and a net margin of 23.81%. The firm's revenue was up 25.0% on a year-over-year basis. During the same period in the previous year, the business earned $0.27 earnings per share. View Healthequity's Earnings History. When is Healthequity's next earnings date? Healthequity is scheduled to release their next quarterly earnings announcement on Tuesday, December 4th 2018. View Earnings Estimates for Healthequity. What guidance has Healthequity issued on next quarter's earnings? Healthequity issued an update on its FY19 earnings guidance on Tuesday, September, 4th. The company provided earnings per share guidance of $0.98-1.05 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.92. The company issued revenue guidance of $279-285 million, compared to the consensus revenue estimate of $282.50 million. What price target have analysts set for HQY? 12 equities research analysts have issued 1-year price targets for Healthequity's shares. Their predictions range from $69.00 to $110.00. On average, they expect Healthequity's stock price to reach $95.1667 in the next year. This suggests a possible upside of 9.5% from the stock's current price. View Analyst Price Targets for Healthequity. What is the consensus analysts' recommendation for Healthequity? 12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Healthequity in the last year. There are currently 3 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Healthequity. What are Wall Street analysts saying about Healthequity stock? Here are some recent quotes from research analysts about Healthequity stock: 1. According to Zacks Investment Research, "Health Equity outperformed its industry in a year’s time. With strong Health Savings Account (HSA) member growth, the company is currently the third largest HSA custodian by market share. In addition to HSA, HealthEquity now offers health reimbursement arrangement (HRA) and a health flexible spending account (FSA) to regional employers. Apart from this, HealthEquity’s 401(K) solution that reduces the cost, risk and work of managing a retirement plan buoys optimism. By the end of the first quarter of fiscal 2019, management was optimistic regarding the launch of HealthEquity retirement services. However, the company faces stiff competition in the Medical Services markets. The company is required to comply with strict Treasury Regulations formulated by the Internal Revenue Service or the IRS. The stock looks a bit overvalued at the moment. On the brighter side, The company" (8/7/2018) 2. Cantor Fitzgerald analysts commented, ". We reiterate our Neutral rating on HQY shares and increase our price target to $68 from $65. After the close on Monday, June 4, HQY reported solid 1QFY19 (ended April) results that were above FactSet consensus and our estimates. Adjusted EPS were $0.31 vs. our estimate of $0.27. The company raised its FY19 revenue and EPS guidance yet again at it continues to gain market share (number of accounts and assets). We believe HQY remains well positioned due to its strong platform and continued adoption of high-deductible health plans and HSAs." (6/4/2018) Who are some of Healthequity's key competitors? Some companies that are related to Healthequity include Pinduoduo (PDD), Global Payments (GPN), FleetCor Technologies (FLT), Ctrip.Com International (CTRP), Total System Services (TSS), CoStar Group (CSGP), Msci (MSCI), Broadridge Financial Solutions (BR), Mercadolibre (MELI), Alliance Data Systems (ADS), Akamai Technologies (AKAM), GrubHub (GRUB), Nielsen (NLSN), CIELO S A/S (CIOXY) and The Western Union (WU). Who are Healthequity's key executives? Healthequity's management team includes the folowing people: Mr. Jon Kessler, Pres, CEO & Director (Age 50)Mr. Darcy G. Mott, Exec. VP & CFO (Age 65)Ms. Ashley Dreier, Exec. VP, CTO & Chief Information Officer (Age 45)Mr. William Robert Otten, Exec. VP of Sales (Age 53)Mr. Edward Bloomberg, Exec. VP & COO (Age 42) Who are Healthequity's major shareholders? Healthequity's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Peregrine Capital Management LLC (0.57%), Barometer Capital Management Inc. (0.14%), Scout Investments Inc. (0.13%), Bank of Montreal Can (0.10%), Seven Eight Capital LP (0.06%) and Nisa Investment Advisors LLC (0.04%). Company insiders that own Healthequity stock include Adrian T Dillon, Angelique Christine Hill, Ashley Dreier, Berkley Capital, Llc, Darcy G Mott, Delano Ladd, Evelyn S Dilsaver, Frank Corvino, Frank Medici, Gary D Robinson, Jon Kessler, Jon Soldan, Manu S Rana, Matthew Sydney and Stephen Neeleman. View Institutional Ownership Trends for Healthequity. Which institutional investors are selling Healthequity stock? HQY stock was sold by a variety of institutional investors in the last quarter, including Peregrine Capital Management LLC, Scout Investments Inc., Louisiana State Employees Retirement System, Bank of Montreal Can and Sheets Smith Wealth Management. Company insiders that have sold Healthequity company stock in the last year include Angelique Christine Hill, Ashley Dreier, Berkley Capital, Llc, Darcy G Mott, Delano Ladd, Evelyn S Dilsaver, Frank Medici, Gary D Robinson, Jon Kessler, Jon Soldan and Stephen Neeleman. View Insider Buying and Selling for Healthequity. Which institutional investors are buying Healthequity stock? HQY stock was bought by a variety of institutional investors in the last quarter, including Barometer Capital Management Inc., Seven Eight Capital LP, Nisa Investment Advisors LLC, Strs Ohio, Jaffetilchin Investment Partners LLC, Cerebellum GP LLC and Xact Kapitalforvaltning AB. View Insider Buying and Selling for Healthequity. How do I buy shares of Healthequity? Shares of HQY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Healthequity's stock price today? One share of HQY stock can currently be purchased for approximately $86.92. How big of a company is Healthequity? Healthequity has a market capitalization of $5.39 billion and generates $229.52 million in revenue each year. The company earns $47.36 million in net income (profit) each year or $0.54 on an earnings per share basis. Healthequity employs 1,027 workers across the globe. What is Healthequity's official website? The official website for Healthequity is http://www.healthequity.com. How can I contact Healthequity? Healthequity's mailing address is 15 WEST SCENIC POINTE DRIVE SUITE 100, DRAPER UT, 84020. The company can be reached via phone at 801-727-1000 or via email at [email protected] MarketBeat Community Rating for Healthequity (NASDAQ HQY)Community Ranking: 2.8 out of 5 ( )Outperform Votes: 294 (Vote Outperform)Underperform Votes: 232 (Vote Underperform)Total Votes: 526MarketBeat's community ratings are surveys of what our community members think about Healthequity and other stocks. Vote "Outperform" if you believe HQY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HQY will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 10/21/2018 by MarketBeat.com StaffFeatured Article: What are trading strategies for the 52-week high/low?